Council Post: Data Is Pharma's Next Blockbuster
Copyright 2022 Forbes Media LLC
business
2022-05-27 12:15:00

Anupam Nandwana is co-founder and CEO of P360, a leading developer of technology for the life sciences industry. getty When it comes to bringing life-saving therapeutics to market, the first significant investment for pharmaceutical companies is within research and development, which includes drug discovery, drug development and clinical research. The general rule of thumb within the industry is that 25% of a pharmaceutical company's annual budget goes to R&D. In 2019 alone, the Congressional Budget Office estimated that the industry spent upwards of $83 billion on R&D.
